bioreactor

How Much Daratumumab is Enough for Genmab?

Some of you may have read the latest information on Dara’s outstanding results.  It had a 36% response rate for individuals with relapsed refractory multiple myeloma.  To give you a frame of reference Kyprolis received approval with only a 23% response.  So this gives us a strong indication that the Dara will be approved in the near future, but how …

Read more.